Insiders · Profile

Clancy Paul J

Director at Incyte · Executive VP and CFO at Biogen. Filing since 12 Feb 2008. CIK 0001409601

Company
Date
Role
Action
Shares
Amount
Of holding
19 May 2026
Director
Sold on a plan
15,000
$1.42M
38.7%
25 Apr 2017
Executive VP and CFO
Sold, plan not stated
9,892
$2.87M
47.8%
13 Mar 2017
Executive VP and CFO
Sold, plan not stated
9,891
$2.88M
32.3%
18 Sep 2013
Executive VP and CFO
Sold, plan not stated
26,785
$6.56M
79.1%
16 Sep 2013
Executive VP and CFO
Sold, plan not stated
99,030
$23.60M
93.3%
30 Apr 2013
Executive VP and CFO
Sold, plan not stated
14,489
$3.26M
67.2%
29 Apr 2013
Executive VP and CFO
Sold, plan not stated
9,123
$2.00M
29.7%
1 Feb 2012
Executive VP and CFO
Sold, plan not stated
21,400
$2.57M
50.3%
3 Jan 2012
Executive VP and CFO
Sold, plan not stated
20,244
$2.27M
48.9%
28 Apr 2011
Executive VP and CFO
Sold, plan not stated
19,716
$1.95M
31.8%
19 Sep 2008
Executive VP and CFO
Sold, plan not stated
1,553
$77.65K
3.7%
8 Aug 2008
Executive VP and CFO
Sold, plan not stated
568
$28.78K
1.3%
1 Jul 2008
CFO
Sold, plan not stated
4,208
$235.68K
10.1%
21 Feb 2008
CFO
Sold, plan not stated
2,183
$131.46K
4.9%
12 Feb 2008
CFO
Sold, plan not stated
958
$58.40K
3.1%
15 decisions on file.